Social Sentiment Ticker Powered by AI
Social Sentiment Ticker Powered by AI
Download App
Master the Markets with TradeZing PLUS’s AI Powered Tools
Learn More
Host your events on tradezing app
COMMUNITY AUDIO ROOMS
No available audio rooms
Upcoming Events
TradeZing
Bitcoins next massive move will shock investors!!! $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCW $GBTC
Bitcoins next massive move will shock investors!!! $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCW $GBTC
8 Day1 Hr33 Min28 Sec
YouTube
Get the TradeZing Newsletter
Supercharge
Your Money Making Potential
Watch your wealth rise with the power of AI research tools only with TradeZing PLUS!
Subscribe Now
EXCLUSIVE
Trade the Day
With Larry Benedict and Eric Shamilov
Trade together with legendary hedge fund manager Larry Benedict every morning before the bell
Everyday at 8:45 AM EST
What is Trade the Day?
Get ahead of the market curve each trading day with Larry Benedict, a distinguished Barron’s Top 100 hedge fund manager and the founder of the Opportunistic Trader ETF (WZRD). With his analyst, Eric Shamilov, Larry provides live, pre-market trading insights and strategic analysis, equipping you with the knowledge to make smart trading decisions.
Not a TradeZing PRO Member?
Subscribe now for exclusive advantages and benefits!
TZ PLUS Cash Back
Latest Feed
May 16, 2024
15 mins ago
Kadant Declares Cash Dividend
WESTFORD, Mass., May 16, 2024 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) announced today that its Board of Directors has approved a quarterly cash dividend to stockholders of $0.32 per share to be paid on August 8, 2024 to stockholders of record as of the close of business on July 11, 2024. Future declarations of dividends are subject to Board approval and may be adjusted as business needs or market conditions change.
181757
News
May 16, 2024
22 mins ago
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., May 16, 2024 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on May 11, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4).
181760
News
May 16, 2024
22 mins ago
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer of Spero Therapeutics, will participate in a fireside chat and be available for one-on-one meetings at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ, to take place on Monday, May 20, 2024, at the NASDAQ World Headquarters New York, NY. Details are as follows:
181759
News
Related on Reddit
Related on X
Related on YouTube
What’s Going on With Intel Stock?
Intel keeps disappointing investors amid the rising stock prices in the semiconductor industry.
Continue Reading
Copied
Related Events
No related events associated to this feed.
Latest Feed
May 16, 2024
15 mins ago
Kadant Declares Cash Dividend
WESTFORD, Mass., May 16, 2024 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) announced today that its Board of Directors has approved a quarterly cash dividend to stockholders of $0.32 per share to be paid on August 8, 2024 to stockholders of record as of the close of business on July 11, 2024. Future declarations of dividends are subject to Board approval and may be adjusted as business needs or market conditions change.
KAI
181757
News
May 16, 2024
22 mins ago
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., May 16, 2024 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on May 11, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4).
ANNX
181760
News
May 16, 2024
22 mins ago
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer of Spero Therapeutics, will participate in a fireside chat and be available for one-on-one meetings at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ, to take place on Monday, May 20, 2024, at the NASDAQ World Headquarters New York, NY. Details are as follows:
SPRO
181759
News
Related on Reddit
Related on X
Related on YouTube
Connect with your community
Introducing Audio Rooms: Engage in real-time discussions on community or news topics with fellow users. Each article or post can instantly create its exclusive audio room, facilitating conversations about subjects directly tied to the article or community post.
Audio Room Title:
What’s Going on With Intel Stock?
Someone already created an audio of this feed.
Join the room
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
0 Comments